The transparency panel also directed that the entire bio- safety data pertaining to all other genetically modified crops in the pipeline be put in the public domain as that is part of voluntary disclosures under Section IV of the RTI Act.
The ministry had objected to the disclosure of the data, saying the information is exempted under the RTI clause related to commercial confidence of the third party -- the Centre for Genetic Manipulation of Crop Plants.
Information Commissioner Sridhar Acharyulu said people should know how and why GM mustard is being permitted or denied because they have to consume the item.
"All documents relating to GEAC recommendation, sub- committee report, revised dossier as recommended and to prepare RARM need to be furnished to the public in general in public interest. Its denial to appellant is not legal," Acharyulu said.
He directed that the environment ministry furnish the certified copy of the Technical Expert Committee (TEC) report and the joint affidavit filed by it and the agriculture ministry in response to the report.
The commissioner said even if the ministry claims exception under Section 8(1)(d), they have to justify the same by substantiating as to how it will breach the commercial confidence of the third party. It added that if so, they can separate the same and give the rest of the information to the appellant.
"It is a policy decision by the public authority which needs to be revealed to the public in general as mandated by Section 4 because they are going to be affected if GM mustard is marked," he said.
The Information Commissioner said it is quite clear that genetically engineered organisms or cells are recognised by the government as an item potentially hazardous to public health.
"The decision-making process should be told along with information about whether such process is adopted, minutes of the meetings, results of clinical trial, and entire information about GM mustard etc. This is in public interest," Acharyulu said.
The order came on an RTI plea by Kavitha Kuruganthi, who had sought a copy of the bio-safety document of GM Mustard that is being experimented in fields for trial in India along with raw data of studies conducted.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
